OPALEYE MANAGEMENT INC. purchased 3.0% of their position (87.80K shares) of GRACE THERAPEUTICS, INC. on the open market
Open‑market purchase worth $158.6K — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 10/26/2026ACC: 0001493152-26-048591
10% Owner
Since Aug 2026
+87.80K
Net shares
Net buyer
$158.6K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
87.80K acquired
Non-Derivative Transactions2
Common Stock, par value $0.0001 per share
Indirect
Shares
+21.39K
Price / share
$1.93
Trade value
$41.19K
% of position
0.7%
10/22/2026
2.95M→2.97M
Common Stock, par value $0.0001 per share
Indirect
Shares
+66.41K
Price / share
$1.77
Trade value
$117.41K
% of position
2.2%
10/26/2026
2.97M→3.04M
Total
Net shares
+87.80K
Net value
$158.60K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 per share Indirect | 10/22/2026 | P · Purchase | +21.39K | $1.93 | $41.19K | 0.7% | 2.95M | 2.97M |
| Common Stock, par value $0.0001 per share Indirect | 10/26/2026 | P · Purchase | +66.41K | $1.77 | $117.41K | 2.2% | 2.97M | 3.04M |
| Total | +87.80K | $158.60K | ||||||
Derivative Transactions0
No derivative transactions reported